 | • レポートコード：QYR9ST00776 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の抗うつ薬市場について調査・分析し、以下の構成でお届け致します。抗うつ薬の種類別には、三環系抗うつ薬、選択的セロトニン再取り込み阻害剤、セロトニン-ノルエピネフリン再取り込み阻害剤、モノアミンオキシダーゼ阻害剤、セロトニン拮抗薬、再取り込み阻害剤、その他に、用途別には、大鬱病性障害、強迫性障害、全般性不安障害、パニック障害、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別抗うつ薬売上データ ・地域別抗うつ薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別抗うつ薬市場規模：三環系抗うつ薬、選択的セロトニン再取り込み阻害剤、セロトニン-ノルエピネフリン再取り込み阻害剤、モノアミンオキシダーゼ阻害剤、セロトニン拮抗薬、再取り込み阻害剤、その他 ・用途別抗うつ薬市場規模：大鬱病性障害、強迫性障害、全般性不安障害、パニック障害、その他 ・主要メーカーの企業情報：Alkermes、Allergan、Bristol-Myers Squibb、Eli Lilly and Company、GlaxoSmithKline、Lundbeck、Merck、Pfizer、TEVA PHARMACEUTICAL INDUSTRIES、TAKEDA PHARMACEUTICAL ・抗うつ薬の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive–compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperactivity disorder (ADHD), addiction, dependence, and sleep disorders. They may be prescribed alone or in combination with other medications.The global Anti-Depressant market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Anti-Depressant market based on company, product type, end user and key regions.
This report studies the global market size of Anti-Depressant in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Anti-Depressant in these regions.
This research report categorizes the global Anti-Depressant market by top players/brands, region, type and end user. This report also studies the global Anti-Depressant market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Alkermes
Allergan
Bristol-Myers Squibb
Eli Lilly and Company
GlaxoSmithKline
Lundbeck
Merck
Pfizer
TEVA PHARMACEUTICAL INDUSTRIES
TAKEDA PHARMACEUTICAL
Market size by Product
Tricyclic Antidepressants
Selective Serotonin Reuptake Inhibitors
Serotonin-Norepinephrine Reuptake Inhibitors
Monoamine Oxidase Inhibitors
Serotonin Antagonist
Reuptake Inhibitors
Others
Market size by End User
Major Depressive Disorder
Obsessive-Compulsive Disorder
Generalized Anxiety Disorder
Panic Disorder
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Anti-Depressant market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Anti-Depressant market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Anti-Depressant companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Anti-Depressant submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Anti-Depressant are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anti-Depressant market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Anti-Depressant Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Anti-Depressant Market Size Growth Rate by Product
1.4.2 Tricyclic Antidepressants
1.4.3 Selective Serotonin Reuptake Inhibitors
1.4.4 Serotonin-Norepinephrine Reuptake Inhibitors
1.4.5 Monoamine Oxidase Inhibitors
1.4.6 Serotonin Antagonist
1.4.7 Reuptake Inhibitors
1.4.8 Others
1.5 Market by End User
1.5.1 Global Anti-Depressant Market Size Growth Rate by End User
1.5.2 Major Depressive Disorder
1.5.3 Obsessive-Compulsive Disorder
1.5.4 Generalized Anxiety Disorder
1.5.5 Panic Disorder
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anti-Depressant Market Size
2.1.1 Global Anti-Depressant Revenue 2014-2025
2.1.2 Global Anti-Depressant Sales 2014-2025
2.2 Anti-Depressant Growth Rate by Regions
2.2.1 Global Anti-Depressant Sales by Regions
2.2.2 Global Anti-Depressant Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Anti-Depressant Sales by Manufacturers
3.1.1 Anti-Depressant Sales by Manufacturers
3.1.2 Anti-Depressant Sales Market Share by Manufacturers
3.1.3 Global Anti-Depressant Market Concentration Ratio (CR5 and HHI)
3.2 Anti-Depressant Revenue by Manufacturers
3.2.1 Anti-Depressant Revenue by Manufacturers (2014-2019)
3.2.2 Anti-Depressant Revenue Share by Manufacturers (2014-2019)
3.3 Anti-Depressant Price by Manufacturers
3.4 Anti-Depressant Manufacturing Base Distribution, Product Types
3.4.1 Anti-Depressant Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-Depressant Product Type
3.4.3 Date of International Manufacturers Enter into Anti-Depressant Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Anti-Depressant Sales by Product
4.2 Global Anti-Depressant Revenue by Product
4.3 Anti-Depressant Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Anti-Depressant Breakdown Data by End User
6 North America
6.1 North America Anti-Depressant by Countries
6.1.1 North America Anti-Depressant Sales by Countries
6.1.2 North America Anti-Depressant Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Anti-Depressant by Product
6.3 North America Anti-Depressant by End User
7 Europe
7.1 Europe Anti-Depressant by Countries
7.1.1 Europe Anti-Depressant Sales by Countries
7.1.2 Europe Anti-Depressant Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-Depressant by Product
7.3 Europe Anti-Depressant by End User
8 Asia Pacific
8.1 Asia Pacific Anti-Depressant by Countries
8.1.1 Asia Pacific Anti-Depressant Sales by Countries
8.1.2 Asia Pacific Anti-Depressant Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Anti-Depressant by Product
8.3 Asia Pacific Anti-Depressant by End User
9 Central & South America
9.1 Central & South America Anti-Depressant by Countries
9.1.1 Central & South America Anti-Depressant Sales by Countries
9.1.2 Central & South America Anti-Depressant Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Anti-Depressant by Product
9.3 Central & South America Anti-Depressant by End User
10 Middle East and Africa
10.1 Middle East and Africa Anti-Depressant by Countries
10.1.1 Middle East and Africa Anti-Depressant Sales by Countries
10.1.2 Middle East and Africa Anti-Depressant Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Anti-Depressant by Product
10.3 Middle East and Africa Anti-Depressant by End User
11 Company Profiles
11.1 Alkermes
11.1.1 Alkermes Company Details
11.1.2 Company Business Overview
11.1.3 Alkermes Anti-Depressant Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Alkermes Anti-Depressant Products Offered
11.1.5 Alkermes Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Company Business Overview
11.2.3 Allergan Anti-Depressant Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Allergan Anti-Depressant Products Offered
11.2.5 Allergan Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Company Business Overview
11.3.3 Bristol-Myers Squibb Anti-Depressant Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Bristol-Myers Squibb Anti-Depressant Products Offered
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Company Details
11.4.2 Company Business Overview
11.4.3 Eli Lilly and Company Anti-Depressant Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Eli Lilly and Company Anti-Depressant Products Offered
11.4.5 Eli Lilly and Company Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 Company Business Overview
11.5.3 GlaxoSmithKline Anti-Depressant Sales, Revenue and Gross Margin (2014-2019)
11.5.4 GlaxoSmithKline Anti-Depressant Products Offered
11.5.5 GlaxoSmithKline Recent Development
11.6 Lundbeck
11.6.1 Lundbeck Company Details
11.6.2 Company Business Overview
11.6.3 Lundbeck Anti-Depressant Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Lundbeck Anti-Depressant Products Offered
11.6.5 Lundbeck Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Company Business Overview
11.7.3 Merck Anti-Depressant Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Merck Anti-Depressant Products Offered
11.7.5 Merck Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Company Business Overview
11.8.3 Pfizer Anti-Depressant Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Pfizer Anti-Depressant Products Offered
11.8.5 Pfizer Recent Development
11.9 TEVA PHARMACEUTICAL INDUSTRIES
11.9.1 TEVA PHARMACEUTICAL INDUSTRIES Company Details
11.9.2 Company Business Overview
11.9.3 TEVA PHARMACEUTICAL INDUSTRIES Anti-Depressant Sales, Revenue and Gross Margin (2014-2019)
11.9.4 TEVA PHARMACEUTICAL INDUSTRIES Anti-Depressant Products Offered
11.9.5 TEVA PHARMACEUTICAL INDUSTRIES Recent Development
11.10 TAKEDA PHARMACEUTICAL
11.10.1 TAKEDA PHARMACEUTICAL Company Details
11.10.2 Company Business Overview
11.10.3 TAKEDA PHARMACEUTICAL Anti-Depressant Sales, Revenue and Gross Margin (2014-2019)
11.10.4 TAKEDA PHARMACEUTICAL Anti-Depressant Products Offered
11.10.5 TAKEDA PHARMACEUTICAL Recent Development
12 Future Forecast
12.1 Anti-Depressant Market Forecast by Regions
12.1.1 Global Anti-Depressant Sales Forecast by Regions 2019-2025
12.1.2 Global Anti-Depressant Revenue Forecast by Regions 2019-2025
12.2 Anti-Depressant Market Forecast by Product
12.2.1 Global Anti-Depressant Sales Forecast by Product 2019-2025
12.2.2 Global Anti-Depressant Revenue Forecast by Product 2019-2025
12.3 Anti-Depressant Market Forecast by End User
12.4 North America Anti-Depressant Forecast
12.5 Europe Anti-Depressant Forecast
12.6 Asia Pacific Anti-Depressant Forecast
12.7 Central & South America Anti-Depressant Forecast
12.8 Middle East and Africa Anti-Depressant Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti-Depressant Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Anti-Depressant Product Picture
Table Anti-Depressant Market Segments
Table Key Manufacturers Anti-Depressant Covered
Table Global Anti-Depressant Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Anti-Depressant Sales Market Share by Product 2014-2025
Figure Tricyclic Antidepressants Product Picture
Table Major Manufacturers of Tricyclic Antidepressants
Figure Selective Serotonin Reuptake Inhibitors Product Picture
Table Major Manufacturers of Selective Serotonin Reuptake Inhibitors
Figure Serotonin-Norepinephrine Reuptake Inhibitors Product Picture
Table Major Manufacturers of Serotonin-Norepinephrine Reuptake Inhibitors
Figure Monoamine Oxidase Inhibitors Product Picture
Table Major Manufacturers of Monoamine Oxidase Inhibitors
Figure Serotonin Antagonist Product Picture
Table Major Manufacturers of Serotonin Antagonist
Figure Reuptake Inhibitors Product Picture
Table Major Manufacturers of Reuptake Inhibitors
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Anti-Depressant Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Major Depressive Disorder
Figure Obsessive-Compulsive Disorder
Figure Generalized Anxiety Disorder
Figure Panic Disorder
Figure Others
Figure Anti-Depressant Report Years Considered
Figure Global Anti-Depressant Market Size 2014-2025 (Million US$)
Figure Global Anti-Depressant Sales 2014-2025 (K Units)
Table Global Anti-Depressant Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Anti-Depressant Sales by Regions 2014-2019 (K Units)
Table Global Anti-Depressant Sales Market Share by Regions 2014-2019
Figure Global Anti-Depressant Sales Market Share by Regions 2014-2019
Figure 2018 Global Anti-Depressant Sales Market Share by Regions
Table Global Anti-Depressant Revenue by Regions 2014-2019 (Million US$)
Table Global Anti-Depressant Revenue Market Share by Regions 2014-2019
Figure Global Anti-Depressant Revenue Market Share by Regions 2014-2019
Figure 2018 Global Anti-Depressant Revenue Market Share by Regions
Table Global Anti-Depressant Sales by Manufacturers (2014-2019) (K Units)
Table Global Anti-Depressant Sales Share by Manufacturers (2014-2019)
Figure Global Anti-Depressant Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Anti-Depressant Revenue by Manufacturers (2014-2019) (Million USD)
Table Anti-Depressant Revenue Share by Manufacturers (2014-2019)
Figure Anti-Depressant Value Share by Manufacturers in 2018
Table Key Manufacturers Anti-Depressant Price (2014-2019) (USD/Unit)
Table Anti-Depressant Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Anti-Depressant Product Type
Table Date of International Manufacturers Enter into Anti-Depressant Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Anti-Depressant Sales by Product (2014-2019) (K Units)
Table Global Anti-Depressant Sales Share by Product (2014-2019)
Figure Global Anti-Depressant Sales Market Share by Product (2014-2019)
Figure Global Anti-Depressant Sales Market Share by Product in 2018
Table Global Anti-Depressant Revenue by Product (2014-2019) (Million US$)
Table Global Anti-Depressant Revenue Share by Product (2014-2019)
Figure Global Anti-Depressant Revenue Market Share by Product (2014-2019)
Figure Global Anti-Depressant Revenue Market Share by Product in 2018
Table Anti-Depressant Price by Product 2014-2019 (USD/Unit)
Table Global Anti-Depressant Sales by End User (2014-2019) (K Units)
Table Global Anti-Depressant Sales Share by End User (2014-2019)
Figure Global Sales Anti-Depressant Market Share by End User (2014-2019)
Figure Global Sales Anti-Depressant Market Share by End User in 2018
Figure North America Anti-Depressant Sales Growth Rate 2014-2019 (K Units)
Figure North America Anti-Depressant Revenue Growth Rate 2014-2019 (Million US$)
Table North America Anti-Depressant Sales by Countries (2014-2019) (K Units)
Table North America Anti-Depressant Sales Market Share by Countries (2014-2019)
Figure 2018 North America Anti-Depressant Sales Market Share by Countries
Table North America Anti-Depressant Revenue by Countries (2014-2019) (Million US$)
Table North America Anti-Depressant Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Anti-Depressant Revenue Market Share by Countries
Figure United States Anti-Depressant Sales Growth Rate (2014-2019) (K Units)
Figure United States Anti-Depressant Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Anti-Depressant Sales Growth Rate (2014-2019) (K Units)
Figure Canada Anti-Depressant Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Anti-Depressant Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Anti-Depressant Revenue Growth Rate (2014-2019) (Million US$)
Table North America Anti-Depressant Sales by Product (2014-2019) (K Units)
Table North America Anti-Depressant Sales Market Share by Product (2014-2019)
Figure 2018 North America Anti-Depressant Market Share by Product
Table North America Anti-Depressant Sales by End User (2014-2019) (K Units)
Table North America Anti-Depressant Sales Market Share by End User (2014-2019)
Figure 2018 North America Anti-Depressant Market Share by End User
Figure Europe Anti-Depressant Sales Growth Rate 2014-2019 (K Units)
Figure Europe Anti-Depressant Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Anti-Depressant Sales by Countries (2014-2019) (K Units)
Table Europe Anti-Depressant Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Anti-Depressant Sales Market Share by Countries
Table Europe Anti-Depressant Revenue by Countries (2014-2019) (Million US$)
Table Europe Anti-Depressant Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Anti-Depressant Revenue Market Share by Countries
Figure Germany Anti-Depressant Sales Growth Rate (2014-2019) (K Units)
Figure Germany Anti-Depressant Revenue Growth Rate (2014-2019) (Million US$)
Figure France Anti-Depressant Sales Growth Rate (2014-2019) (K Units)
Figure France Anti-Depressant Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Anti-Depressant Sales Growth Rate (2014-2019) (K Units)
Figure UK Anti-Depressant Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Anti-Depressant Sales Growth Rate (2014-2019) (K Units)
Figure Italy Anti-Depressant Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Anti-Depressant Sales Growth Rate (2014-2019) (K Units)
Figure Russia Anti-Depressant Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Anti-Depressant Sales by Product (2014-2019) (K Units)
Table Europe Anti-Depressant Sales Market Share by Product (2014-2019)
Figure 2018 Europe Anti-Depressant Market Share by Product
Table Europe Anti-Depressant Sales by End User (2014-2019) (K Units)
Table Europe Anti-Depressant Sales Market Share by End User (2014-2019)
Figure 2018 Europe Anti-Depressant Market Share by End User
Figure Asia Pacific Anti-Depressant Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Anti-Depressant Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Anti-Depressant Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Anti-Depressant Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Anti-Depressant Sales Market Share by Countries
Table Asia Pacific Anti-Depressant Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Anti-Depressant Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Anti-Depressant Revenue Market Share by Countries
Figure China Anti-Depressant Sales Growth Rate (2014-2019) (K Units)
Figure China Anti-Depressant Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Anti-Depressant Sales Growth Rate (2014-2019) (K Units)
Figure Japan Anti-Depressant Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Anti-Depressant Sales Growth Rate (2014-2019) (K Units)
Figure Korea Anti-Depressant Revenue Growth Rate (2014-2019) (Million US$)
Figure India Anti-Depressant Sales Growth Rate (2014-2019) (K Units)
Figure India Anti-Depressant Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Anti-Depressant Sales Growth Rate (2014-2019) (K Units)
Figure Australia Anti-Depressant Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Anti-Depressant Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Anti-Depressant Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Anti-Depressant Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Anti-Depressant Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Anti-Depressant Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Anti-Depressant Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Anti-Depressant Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Anti-Depressant Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Anti-Depressant Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Anti-Depressant Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Anti-Depressant Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Anti-Depressant Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Anti-Depressant Sales by Product (2014-2019) (K Units)
Table Asia Pacific Anti-Depressant Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Anti-Depressant Market Share by Product
Table Asia Pacific Anti-Depressant Sales by End User (2014-2019) (K Units)
Table Asia Pacific Anti-Depressant Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Anti-Depressant Market Share by End User
Figure Central & South America Anti-Depressant Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Anti-Depressant Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Anti-Depressant Sales by Countries (2014-2019) (K Units)
Table Central & South America Anti-Depressant Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Anti-Depressant Sales Market Share by Countries
Table Central & South America Anti-Depressant Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Anti-Depressant Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Anti-Depressant Revenue Market Share by Countries
Figure Brazil Anti-Depressant Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Anti-Depressant Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Anti-Depressant Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Anti-Depressant Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Anti-Depressant Sales by Product (2014-2019) (K Units)
Table Central & South America Anti-Depressant Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Anti-Depressant Market Share by Product
Table Central & South America Anti-Depressant Sales by End User (2014-2019) (K Units)
Table Central & South America Anti-Depressant Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Anti-Depressant Market Share by End User
Figure Middle East and Africa Anti-Depressant Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Anti-Depressant Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Anti-Depressant Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Anti-Depressant Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Anti-Depressant Sales Market Share by Countries
Table Middle East and Africa Anti-Depressant Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Anti-Depressant Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Anti-Depressant Revenue Market Share by Countries
Figure GCC Countries Anti-Depressant Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Anti-Depressant Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Anti-Depressant Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Anti-Depressant Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Anti-Depressant Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Anti-Depressant Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Anti-Depressant Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Anti-Depressant Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Anti-Depressant Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Anti-Depressant Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Anti-Depressant Market Share by Product
Table Middle East and Africa Anti-Depressant Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Anti-Depressant Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Anti-Depressant Market Share by End User
Table Alkermes Company Details
Table Alkermes Anti-Depressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Alkermes Recent Development
Table Allergan Company Details
Table Allergan Anti-Depressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Allergan Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Anti-Depressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Anti-Depressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly and Company Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Anti-Depressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Lundbeck Company Details
Table Lundbeck Anti-Depressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Lundbeck Recent Development
Table Merck Company Details
Table Merck Anti-Depressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Anti-Depressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table TEVA PHARMACEUTICAL INDUSTRIES Company Details
Table TEVA PHARMACEUTICAL INDUSTRIES Anti-Depressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table TEVA PHARMACEUTICAL INDUSTRIES Recent Development
Table TAKEDA PHARMACEUTICAL Company Details
Table TAKEDA PHARMACEUTICAL Anti-Depressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table TAKEDA PHARMACEUTICAL Recent Development
Table Global Anti-Depressant Sales Forecast by Regions 2019-2025 (K Units)
Table Global Anti-Depressant Sales Market Share Forecast by Regions 2019-2025
Table Global Anti-Depressant Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Anti-Depressant Revenue Market Share Forecast by Regions 2019-2025
Table Global Anti-Depressant Sales Forecast by Product 2019-2025 (K Units)
Table Global Anti-Depressant Sales Market Share Forecast by Product 2019-2025
Table Global Anti-Depressant Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Anti-Depressant Revenue Market Share Forecast by Product 2019-2025
Table Global Anti-Depressant Sales Forecast by End User 2019-2025 (K Units)
Table Global Anti-Depressant Sales Market Share Forecast by End User 2019-2025
Figure North America Anti-Depressant Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Anti-Depressant Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Anti-Depressant Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Anti-Depressant Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Anti-Depressant Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Anti-Depressant Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Anti-Depressant Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Anti-Depressant Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Anti-Depressant Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Anti-Depressant Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Anti-Depressant Value Chain
Table Anti-Depressant Customers List
Table Anti-Depressant Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
抗うつ薬の世界市場：インサイト・予測 Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. Antidepressants help maintain balance of various hormones and chemicals in the brain, which helps i…- 双極性障害治療法の世界市場：市場規模・現状・予測 Bipolar disorder, also known as manic depression, is a mental disorder that could lead to periods of depression and elevated mood.The treatment of bipolar disorder includes psychotherapy as well as medications such as mood stabilizers and antipsychotics. In 2018, the global Bipolar Disorder Therapeu…
- 双極性障害の世界市場：市場規模・現状・予測 Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. There are four basic types of bipolar disorder; all of them involve clear changes in mood, energy, and activity le…
- 世界の原油流動点降下剤市場：専門的調査 Pour point depressants (PPD) are chemical additives that influence the shape of wax crystals and therefore the viscosity and yield stress of a crude oil as it is cooled. Typically, pour point depressants are polymers at concentrations of 20-50 percent in a hydrocarbon solvents (e.g. toluene). The gl…
- IDO阻害剤の世界市場：インサイト・予測 The IDO (indoleamine 2,3-dioxygenase 1, IDO1, IDO-1, INDO, indoleamine-pyrrole 2,3-dioxygenase) inhibitors pipeline analysis report includes ongoing clinical and non-clinical trends in the global IDO inhibitors market. Most of the pipeline therapeutics are in early stage of development, the market i…